India, July 3 -- Today's top gainers include SL Science, which was recently listed on the Nasdaq; Chemomab, gearing up for a Phase 3 trial in primary sclerosing cholangitis; Propanc, following the launch of a share repurchase program; and Tectonic, drawing investor attention ahead of key clinical trial catalysts, among others.
Read on.
SL Science on the Move
SL Science Holding Limited (SLBT) led the pack of gainers on Thursday, with shares surging more than 50% on no specific news.
The Taiwan-headquartered preclinical-stage company specialises in developing innovative cellular and gene therapies. Its initial pipeline targets solid tumor indications with significant unmet medical need, including pancreatic cancer and glioblastoma (brain ...